Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeutics

Details for Australian Patent Application No. 2010284329 (hide)

Owner Baxter Healthcare S.A. Baxter International Inc.

Inventors Schaub, Robert G.; McGinness, Kathleen; Nelson, Jennifer; Genga, Ryan; Waters, Emily; Kurz, Jeffrey C.; Diener, John L.

Agent Cullens

Pub. Number AU-A-2010284329

PCT Pub. Number WO2011/022427

Priority 61/353,374 10.06.10 US; 61/234,939 18.08.09 US; 61/367,766 26.07.10 US; 61/366,362 21.07.10 US

Filing date 17 August 2010

Wipo publication date 24 February 2011

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

29 March 2012 PCT application entered the National Phase

  PCT publication WO2011/022427 Priority application(s): WO2011/022427

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010284338-Computer-automated spatial analysis

2010284328-Training device for grenade launchers